Revision History

1 revisions for "The Broken Promise: How the White House Touted a Generic Drug as an Autism Breakthrough — and the FDA Quietly Walked It Back"

Anonymous24 days ago

In September 2025, President Trump and FDA Commissioner Marty Makary publicly announced that the generic drug leucovorin would be approved to treat autism, potentially helping hundreds of thousands of children. Six months later, the FDA approved the drug only for an ultra-rare genetic disorder affecting fewer than one in a million people, citing insufficient evidence for autism — a dramatic reversal that left families scrambling amid a drug shortage the White House's own announcement had created.